The “stacked” pipeline of biotech specialty crops and regulatory/market barriers to coexistence
Loading...
No Access Until
Permanent Link(s)
Other Titles
Author(s)
Abstract
Biotech specialty crops face a number of potential barriers. Regulatory uncertainty over new plant-breeding methods and costly overseas approvals could complicate plans for commercialization. Stacking a generic crop aids innovators in the marketplace, but generic crops may need the regulatory data held by patent holders to achieve regulatory approval. Sustainability standards may arbitrarily deny use of biotechnology. Any innovator heading into this sector will need to be aware of all the potential threats awaiting these exciting opportunities in genetic engineering of biotech crops.
Journal / Series
Volume & Issue
Description
Sponsorship
Date Issued
2013
Publisher
NABC
Keywords
Agricultural biotechnology; specialty crops; transgenic papaya; stakeholders; genetic engineering; GE; GMO; regulation; food safety; USDA; novel traits; premarket approval; intellectual property; patents; human health impacts; synthetic genomics
Location
Effective Date
Expiration Date
Sector
Employer
Union
Union Local
NAICS
Number of Workers
Committee Chair
Committee Co-Chair
Committee Member
Degree Discipline
Degree Name
Degree Level
Related Version
Related DOI
Related To
Related Part
Based on Related Item
Has Other Format(s)
Part of Related Item
Related To
Related Publication(s)
Link(s) to Related Publication(s)
References
Link(s) to Reference(s)
Previously Published As
Government Document
ISBN
ISMN
ISSN
Other Identifiers
Rights
Attribution-NonCommercial-NoDerivatives 4.0 International
Types
book chapter